a healthy society through the latest optimal medical device technologies
マ
ー
ジ
ン
指
定
2 . 0 cm
マージン指定1.5cm4
Japan Lifeline in Figures
マ
ー
ジ
ン
指
定
2 . 0 cm
Consolidated Net Sales
(FYE March 2023)
¥51.7bln
Growth Rate*1 of AF Ablation Cases
CAGR +6%
Operating Profit Margin
(FYE March 2023)
20.9%
Sales Offices in Japan
(At the end of FYE March 2023)
48 offices
In-house Products
Sales Ratio
(FYE March 2023)
54.9%
Number of Employees
(At the end of FYE March 2023)
1,166
マ
ー
ジ
ン
指
定
2 . 0 cm
*1 Our estimate of the growth rate of the number of ablation cases from FYE March 2023.
マージン指定1.5cm5
Attachments
Original Link
Original Document
Permalink
Disclaimer
JLL - Japan Lifeline Co. Ltd. published this content on 12 June 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 June 2023 06:26:09 UTC.
Japan Lifeline Co., Ltd. is a Japan-based company mainly engaged in the import, manufacture and sale of cardiac circulators and other medical devices. The Company is mainly engaged in the production of rhythm devices, electrophysiological (EP) and ablations, surgical products and intervention products. The rhythm devices include cardiac pacemakers, implantable cardioverter defibrillator (ICD), cardiac resynchronization therapy defibrillator (CRT-D) and other rhythm devices. The EP and ablations include EP catheters for cardiac arrhythmia examination, ablation catheters for arrhythmia treatment and other EP and ablations. The surgical products include prosthetic heart valves and annuloplasty rings for heart disease surgical treatment, vascular grafts, open stent grafts and stent grafts for aortic disease treatment, as well as other surgical products. The intervention products include balloon catheters, guide wires, penetration catheters and other intervention products.
JAPAN LIFELINE CO., LTD. 
